Logo image of NEOEN.PA

Neoen SA (NEOEN.PA) Stock Fundamental Analysis

EPA:NEOEN - Euronext Paris - Matif - FR0011675362 - Common Stock - Currency: EUR

39  +0.28 (+0.72%)

Fundamental Rating

3

NEOEN gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 21 industry peers in the Independent Power and Renewable Electricity Producers industry. While NEOEN is still in line with the averages on profitability rating, there are concerns on its financial health. NEOEN is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

NEOEN had positive earnings in the past year.
NEOEN had a positive operating cash flow in the past year.
In the past 5 years NEOEN has always been profitable.
Each year in the past 5 years NEOEN had a positive operating cash flow.
NEOEN.PA Yearly Net Income VS EBIT VS OCF VS FCFNEOEN.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500M -1B

1.2 Ratios

NEOEN's Return On Assets of 0.60% is in line compared to the rest of the industry. NEOEN outperforms 45.45% of its industry peers.
Looking at the Return On Equity, with a value of 1.95%, NEOEN is in line with its industry, outperforming 45.45% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 3.29%, NEOEN is in line with its industry, outperforming 50.00% of the companies in the same industry.
Industry RankSector Rank
ROA 0.6%
ROE 1.95%
ROIC 3.29%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NEOEN.PA Yearly ROA, ROE, ROICNEOEN.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6

1.3 Margins

NEOEN has a Profit Margin of 6.55%. This is comparable to the rest of the industry: NEOEN outperforms 59.09% of its industry peers.
In the last couple of years the Profit Margin of NEOEN has declined.
NEOEN's Operating Margin of 43.41% is amongst the best of the industry. NEOEN outperforms 81.82% of its industry peers.
In the last couple of years the Operating Margin of NEOEN has declined.
NEOEN has a better Gross Margin (98.73%) than 100.00% of its industry peers.
NEOEN's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 43.41%
PM (TTM) 6.55%
GM 98.73%
OM growth 3Y-9.99%
OM growth 5Y-4.46%
PM growth 3Y-33.81%
PM growth 5Y-24.17%
GM growth 3Y-0.55%
GM growth 5Y-0.13%
NEOEN.PA Yearly Profit, Operating, Gross MarginsNEOEN.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80 100

More info and screens

1

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), NEOEN is destroying value.
NEOEN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
NEOEN.PA Yearly Shares OutstandingNEOEN.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M
NEOEN.PA Yearly Total Debt VS Total AssetsNEOEN.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2B 4B 6B

2.2 Solvency

NEOEN has an Altman-Z score of 0.84. This is a bad value and indicates that NEOEN is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 0.84, NEOEN perfoms like the industry average, outperforming 54.55% of the companies in the same industry.
A Debt/Equity ratio of 1.50 is on the high side and indicates that NEOEN has dependencies on debt financing.
With a Debt to Equity ratio value of 1.50, NEOEN is not doing good in the industry: 63.64% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.5
Debt/FCF N/A
Altman-Z 0.84
ROIC/WACC0.46
WACC7.19%
NEOEN.PA Yearly LT Debt VS Equity VS FCFNEOEN.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B 3B

2.3 Liquidity

NEOEN has a Current Ratio of 0.71. This is a bad value and indicates that NEOEN is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.71, NEOEN is doing worse than 72.73% of the companies in the same industry.
A Quick Ratio of 0.70 indicates that NEOEN may have some problems paying its short term obligations.
NEOEN has a Quick ratio of 0.70. This is in the lower half of the industry: NEOEN underperforms 72.73% of its industry peers.
Industry RankSector Rank
Current Ratio 0.71
Quick Ratio 0.7
NEOEN.PA Yearly Current Assets VS Current LiabilitesNEOEN.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M 1B

More info and screens

6

3. Growth

3.1 Past

The earnings per share for NEOEN have decreased strongly by -73.18% in the last year.
The earnings per share for NEOEN have been decreasing by -25.13% on average. This is quite bad
Looking at the last year, NEOEN shows a very strong growth in Revenue. The Revenue has grown by 50.42%.
Measured over the past years, NEOEN shows a quite strong growth in Revenue. The Revenue has been growing by 16.06% on average per year.
EPS 1Y (TTM)-73.18%
EPS 3Y-38.86%
EPS 5Y-25.13%
EPS Q2Q%-80.15%
Revenue 1Y (TTM)50.42%
Revenue growth 3Y16.91%
Revenue growth 5Y16.06%
Sales Q2Q%115.48%

3.2 Future

NEOEN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 26.91% yearly.
Based on estimates for the next years, NEOEN will show a quite strong growth in Revenue. The Revenue will grow by 19.55% on average per year.
EPS Next Y68.16%
EPS Next 2Y52.21%
EPS Next 3Y41.7%
EPS Next 5Y26.91%
Revenue Next Year34.03%
Revenue Next 2Y23.83%
Revenue Next 3Y26.04%
Revenue Next 5Y19.55%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
NEOEN.PA Yearly Revenue VS EstimatesNEOEN.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 500M 1B 1.5B 2B
NEOEN.PA Yearly EPS VS EstimatesNEOEN.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0.5 1 1.5 2 2.5

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 139.29, which means the current valuation is very expensive for NEOEN.
The rest of the industry has a similar Price/Earnings ratio as NEOEN.
Compared to an average S&P500 Price/Earnings ratio of 28.78, NEOEN is valued quite expensively.
The Price/Forward Earnings ratio is 45.11, which means the current valuation is very expensive for NEOEN.
NEOEN's Price/Forward Earnings is on the same level as the industry average.
NEOEN is valuated expensively when we compare the Price/Forward Earnings ratio to 21.32, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 139.29
Fwd PE 45.11
NEOEN.PA Price Earnings VS Forward Price EarningsNEOEN.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

NEOEN's Enterprise Value to EBITDA is on the same level as the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 18.6
NEOEN.PA Per share dataNEOEN.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 15

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
A more expensive valuation may be justified as NEOEN's earnings are expected to grow with 41.70% in the coming years.
PEG (NY)2.04
PEG (5Y)N/A
EPS Next 2Y52.21%
EPS Next 3Y41.7%

More info and screens

2

5. Dividend

5.1 Amount

With a yearly dividend of 0.38%, NEOEN is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 4.07, NEOEN has a dividend in line with its industry peers.
Compared to an average S&P500 Dividend Yield of 2.46, NEOEN's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.38%

5.2 History

The dividend of NEOEN decreases each year by -9.76%.
Dividend Growth(5Y)-9.76%
Div Incr Years2
Div Non Decr Years2
NEOEN.PA Yearly Dividends per shareNEOEN.PA Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 0.05 0.1

5.3 Sustainability

NEOEN pays out 11.22% of its income as dividend. This is a sustainable payout ratio.
DP11.22%
EPS Next 2Y52.21%
EPS Next 3Y41.7%
NEOEN.PA Yearly Income VS Free CF VS DividendNEOEN.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200M -400M -600M -800M -1B
NEOEN.PA Dividend Payout.NEOEN.PA Dividend Payout, showing the Payout Ratio.NEOEN.PA Dividend Payout.PayoutRetained Earnings

More info and screens

Neoen SA

EPA:NEOEN (3/17/2025, 7:00:00 PM)

39

+0.28 (+0.72%)

Chartmill FA Rating
GICS SectorUtilities
GICS IndustryGroupUtilities
GICS IndustryIndependent Power and Renewable Electricity Producers
Earnings (Last)03-05 2025-03-05/amc
Earnings (Next)07-23 2025-07-23
Inst Owners22.16%
Inst Owner ChangeN/A
Ins Owners0.58%
Ins Owner ChangeN/A
Market Cap5.97B
Analysts50
Price Target38.87 (-0.33%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.38%
Yearly Dividend0.02
Dividend Growth(5Y)-9.76%
DP11.22%
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.01%
PT rev (3m)0.01%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-7.6%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.29%
Valuation
Industry RankSector Rank
PE 139.29
Fwd PE 45.11
P/S 7.56
P/FCF N/A
P/OCF 17.67
P/B 2.25
P/tB 2.71
EV/EBITDA 18.6
EPS(TTM)0.28
EY0.72%
EPS(NY)0.86
Fwd EY2.22%
FCF(TTM)-7.42
FCFYN/A
OCF(TTM)2.21
OCFY5.66%
SpS5.16
BVpS17.36
TBVpS14.39
PEG (NY)2.04
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.6%
ROE 1.95%
ROCE 4.67%
ROIC 3.29%
ROICexc 3.55%
ROICexgc 3.8%
OM 43.41%
PM (TTM) 6.55%
GM 98.73%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-9.99%
OM growth 5Y-4.46%
PM growth 3Y-33.81%
PM growth 5Y-24.17%
GM growth 3Y-0.55%
GM growth 5Y-0.13%
F-Score5
Asset Turnover0.09
Health
Industry RankSector Rank
Debt/Equity 1.5
Debt/FCF N/A
Debt/EBITDA 7.17
Cap/Depr 696.08%
Cap/Sales 186.82%
Interest Coverage 2.45
Cash Conversion 60.95%
Profit Quality N/A
Current Ratio 0.71
Quick Ratio 0.7
Altman-Z 0.84
F-Score5
WACC7.19%
ROIC/WACC0.46
Cap/Depr(3y)629.78%
Cap/Depr(5y)601.65%
Cap/Sales(3y)232.24%
Cap/Sales(5y)220.03%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-73.18%
EPS 3Y-38.86%
EPS 5Y-25.13%
EPS Q2Q%-80.15%
EPS Next Y68.16%
EPS Next 2Y52.21%
EPS Next 3Y41.7%
EPS Next 5Y26.91%
Revenue 1Y (TTM)50.42%
Revenue growth 3Y16.91%
Revenue growth 5Y16.06%
Sales Q2Q%115.48%
Revenue Next Year34.03%
Revenue Next 2Y23.83%
Revenue Next 3Y26.04%
Revenue Next 5Y19.55%
EBIT growth 1Y13.68%
EBIT growth 3Y5.23%
EBIT growth 5Y10.88%
EBIT Next Year140.75%
EBIT Next 3Y48.35%
EBIT Next 5Y31.06%
FCF growth 1Y-57.48%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y4%
OCF growth 3Y6.96%
OCF growth 5Y12.84%